News

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing...

"MC0_8230" via Wikimedia Commons licensed under CC by 2.0 

This report documents a deliberate assault on disabled people in...

a robot solving math problems
By Kelsey Piper, Vox | 11.28.2022

In 2018 at the World Economic Forum in Davos, Google CEO Sundar Pichai had something to say: “AI is...

police car
By Amos Barshad, The Nation | 11.28.2022

In the fall of 2017, I sat in a windowless back room in O’Neill’s bar in the Maspeth neighborhood of...

sad woman
By Heather Radke, TIME | 11.26.2022

The first dressing room I remember was at Hudson’s, a Detroit-based department store where middle-class people in my town went...

a bunch of sperm on a black background
By Jessica Hamzelou, MIT Technology Review | 11.25.2022

Peter Zhu was just 19 years old when he died following a skiing accident in West Point, New York. His...

gattaca globe
By Dov Greenbaum and Mark Gerstein, Nature | 11.24.2022

It has been 25 years since the release of GATTACA, a film that tells the story of a credible...

virus
By Heidi Ledford, Nature | 11.23.2022

A systematic sweep of viral genomes has revealed a trove of potential CRISPR-based genome-editing tools.

CRISPR–Cas systems are common in...

FDA sign outside of building
By Sara Reardon, Nature | 11.23.2022

David Bennett’s heart was failing. The 57-year-old handyman from Maryland had weeks to live and, because he had a history...

red blood cells
By Edward Helmore, The Guardian | 11.23.2022

US drug regulators have approved a one-off gene-therapy treatment for adults with the genetic blood disorder hemophilia B that frees...